Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Laboratory Analytical Instruments

Pacific Biosciences of California, Inc. to acquire Omniome

Announced Jul 20, 2021 · Closed Sep 20, 2021 · Private target

Deal value$600M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationCash and stock

Transaction

Acquirer
Pacific Biosciences of California, Inc. (PACB)
Target
Omniome
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Sep 20, 2021

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
Not disclosed
To the target
Jefferies

Classification

Sector
Healthcare
Buyer's industry
Laboratory Analytical Instruments
Sources
  • 8-K (EX-99.1) · Jul 20, 2021

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.